Relationship of Paroxysmal Atrial Tachyarrhythmias to Volume Overload

BACKGROUND: Clinical experience suggests that atrial tachyarrhythmias (ATs) are a frequent comorbidity in heart failure patients with left ventricular systolic dysfunction and that volume overload may increase AT susceptibility. However, substantiating this apparent relationship in free-living patients is difficult. Recently, certain implantable cardioverter-defibrillators provide, by measuring transpulmonary electric bioimpedance, an index of intrathoracic fluid status (OptiVol index [OI]). The goal of this study was to determine whether periods of greater intrathoracic fluid congestion (as detected by OI) correspond with increased AT event frequency. METHODS AND RESULTS: This analysis retrospectively assessed the relation between AT events and OI estimate of volume overload in patients with left ventricular systolic dysfunction and OI-capable implantable cardioverter-defibrillators. OI values were stratified into 3 levels: group 1, \u3c40; group 2, 40 to 60; and group 3, \u3e60. An OI threshold-crossing event was defined as OI \u3e or = 60, a value previously associated with clinically significant volume overload. Findings in 59 patients (mean left ventricular ejection fraction, 24%) with 225 follow-up visits (mean, 3.8 visits per patient) were evaluated. AT prevalence was 73%. AT frequency (percent of patients visits with at least 1 episode of AT since previous device interrogation) was greater in group 3 versus group 1 (P=0.0342). Finally, in terms of temporal sequence, AT episodes preceded OI threshold-crossing event in 43% of incidences, followed threshold-crossing event in 29%, and was simultaneous or indeterminate in the remainder. CONCLUSIONS: These findings not only support the view that worsening pulmonary congestion is associated with increased AT frequency in patients with left ventricular dysfunction but also suggest that AT events may be responsible for triggering episodic pulmonary congestion more often than previously suspected

Cardiorespiratory interactions and blood flow generation during cardiac arrest and other states of low blood flow. Curr Opin Crit Care 9

Purpose of review Recent advances in cardiopulmonary resuscitation have shed light on the importance of cardiorespiratory interactions during shock and cardiac arrest. This review focuses on recently published studies that evaluate factors that determine preload during chest compression, methods that can augment preload, and the detrimental effects of hyperventilation and interrupting chest compressions. Recent findings Refilling of the ventricles, so-called ventricular preload, is diminished during cardiovascular collapse and resuscitation from cardiac arrest. In light of the potential detrimental effects and challenges of large-volume fluid resuscitations, other methods have increasing importance. During cardiac arrest, active decompression of the chest and impedance of inspiratory airflow during the recoil of the chest work by increasing negative intrathoracic pressure and, hence, increase refilling of the ventricles and increase cardiac preload, with improvement in survival. Conversely, increased frequency of ventilation has detrimental effects on coronary perfusion pressure and survival rates in cardiac arrest and severe shock. Prolonged interruption of chest compressions for delivering single-rescuer ventilation or analyzing rhythm before shock delivery is associated with decreased survival rate. Summary Cardiorespiratory interactions are of profound importance in states of cardiovascular collapse in which increased negative intrathoracic pressure during decompression of the chest has a favorable effect and increased intrathoracic pressure with ventilation has a detrimental effect on survival rate. (CPR). Despite this long history, our understanding of how chest compressions during cardiac arrest generate forward blood flow remains incomplete and divided into two schools of thought: the cardiac pump theory and the thoracic pump theory. Initially, the cardiac pump theory predominated. It was thought that pressing the heart between the sternum and spine generated the force to propel the blood from the ventricles to the lungs and systemic circulation, whereas recoiling of the chest promoted flow into the ventricles. It was not until 1976, when Criley et al. [3] described "cough resuscitation," that the theory of a thoracic pump mechanism emerged. Based on the thoracic pump theory, the heart was thought to function more as a passive conduit, while during each chest compression, transmission of blood from the lungs to the systemic circulation occurred because of increased pressure in the intrathoracic arteries. The work of Weisfeldt and Halperin [4] further supported this hypothesis. Echocardiographic observations [5,6] have shown that both the cardiac and thoracic pump mechanisms are operative, but it is still unclear what determines which mechanism predominates. By contrast, it is during the decompression phase that venous blood flow returns to the heart secondary to differences between the extrathoracic and intrathoracic veins. As pressures decrease in the thorax relative to the extrathoracic vasculature, blood moves back to the right heart via the vena cava and, to a lesser extent, back to the left heart via the aorta. In reality, both the thoracic pump and cardiac pump mechanisms play an important role at different times after cardiac arrest. Keywords Factors that might affect the relative roles of the cardiac and thoracic pumps include the time between arrest and CPR, venous return, total body volume status, cardiac chamber blood volume, cardiac valve integrity, vascular compliance, chest compression rate and depth, ability of the chest wall to recoil fully, duration of compression in relation to decompression, chest wall elasticity, airway pressure, ventilation rate, body habitus, hypoxia, hypercarbia, vasoactive medications, and presenting cardiac rhythm. The amount of blood flow to the heart at any given time may be the most important determinant of survival. Indeed, the amount of blood flow that returns to Cardiac Arrhythmia Center, University of Minnesota, Minneapolis, Minnesota, USA. Dr. Lurie is a coinventor of the inspiratory impedance threshold device and active compression/decompression cardiopulmonary resuscitation technology and founded a company, CPRx LLC, to develop this device. There are no other conflicts of interest